Asia Pacific: The Hyaluronidase market in Asia Pacific is projected to witness substantial growth owing to the growing geriatric population, increasing healthcare expenditure, and rising awareness about aesthetic procedures in countries like China, Japan, and South Korea.
Europe: In Europe, the Hyaluronidase market is likely to experience steady growth with countries like the United Kingdom, Germany, and France playing a crucial role in market expansion. The increasing adoption of Hyaluronidase in various medical and cosmetic applications is expected to drive market growth in the region.